Eliglustat Tartrate

Description

Eliglustat Tartrate · CAS 928659-70-5 · C50H78N4O14. UNII N0493335P3.

Identification

Computed Descriptors

Physical description & handling notes

• Agalsidase alfa is a recombinant human α-galactosidase A used as enzyme replacement therapy in the treatment of Fabry disease. It has a long duration of action and a wide therapeutic index. Patients should be counselled regarding the risk of infusion related reactions and hypersensitivity.

Documented Uses

• Agalsidase alfa is indicated in the treatment of Fabry disease.
• Breast Feeding; Lactation; Milk, Human; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors
• Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
• A - Alimentary tract and metabolism
• A16 - Other alimentary tract and metabolism products
• A16A - Other alimentary tract and metabolism products

Synonyms

Eliglustat tartrate; 928659-70-5; eliglustat hemitartrate; GENZ-112638; Genz 112638; N0493335P3; CHEBI:83353; DTXSID50239166; CERDELGA COMPONENT ELIGLUSTAT TARTRATE; RefChem:56881; DTXCID70161657; Cerdelga; Eliglustat (hemitartrate); 104138-64-9; Eliglustat tartrate [USAN]; Eliglustat (Tartrate)

Frequently Asked Questions

What are the CAS number and molecular formula of Eliglustat Tartrate?

CAS 928659-70-5; molecular formula C50H78N4O14; molecular weight — g/mol.

What other names is Eliglustat Tartrate known by?

Eliglustat tartrate, 928659-70-5, eliglustat hemitartrate, GENZ-112638, Genz 112638, N0493335P3.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.